Robert W. Baird Forecasts Strong Price Appreciation for Mettler-Toledo International (NYSE:MTD) Stock

Mettler-Toledo International (NYSE:MTD) had its price target boosted by research analysts at Robert W. Baird from $1,608.00 to $1,815.00 in a note issued to investors on Monday, Benzinga reports. The firm currently has a “neutral” rating on the medical instruments supplier’s stock. Robert W. Baird‘s price objective suggests a potential upside of 5.32% from the company’s current price.

MTD has been the topic of a number of other reports. UBS Group started coverage on shares of Mettler-Toledo International in a report on Wednesday, September 9th. They issued a “neutral” rating and a $1,460.00 price target on the stock. Rothschild & Co Redburn started coverage on shares of Mettler-Toledo International in a report on Wednesday, September 2nd. They set a “sell” rating and a $1,200.00 price objective for the company. Barclays boosted their price objective on shares of Mettler-Toledo International from $1,575.00 to $1,700.00 and gave the company an “overweight” rating in a research report on Wednesday, October 7th. Jefferies Financial Group upped their target price on shares of Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Finally, Royal Bank Of Canada began coverage on shares of Mettler-Toledo International in a research note on Tuesday, September 1st. They set a “sector perform” rating and a $1,515.00 price target for the company. Six research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $1,516.92.

Mettler-Toledo International Trading Up 0.1%

MTD opened at $1,723.32 on Monday. The stock has a market cap of $34.53 billion, a price-to-earnings ratio of 37.34, a P/E/G ratio of 3.46 and a beta of 1.16. The stock’s 50 day moving average price is $1,524.65 and its 200-day moving average price is $1,345.95. Mettler-Toledo International has a one year low of $1,023.05 and a one year high of $1,806.58. The company has a debt-to-equity ratio of 25.28, a quick ratio of 0.75 and a current ratio of 1.10.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 5th. The medical instruments supplier reported $12.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $12.13 by $0.44. Mettler-Toledo International had a return on equity of 15,012.71% and a net margin of 22.25%. The firm had revenue of $1.09 billion during the quarter, compared to analyst estimates of $1.07 billion. During the same period last year, the company earned $11.15 EPS. Mettler-Toledo International’s quarterly revenue was up 6.3% compared to the same quarter last year. On average, equities analysts forecast that Mettler-Toledo International will post 47.49 EPS for the current year.

Insiders Place Their Bets

In other Mettler-Toledo International news, CEO Patrick Kaltenbach sold 942 shares of the stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total transaction of $1,342,350.00. Following the sale, the chief executive officer owned 4,480 shares of the company’s stock, valued at approximately $6,384,000. This trade represents a 17.37% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.71% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Mettler-Toledo International

A number of hedge funds have recently made changes to their positions in the stock. Phoenix Financial Ltd. grew its stake in Mettler-Toledo International by 7.6% during the 3rd quarter. Phoenix Financial Ltd. now owns 183 shares of the medical instruments supplier’s stock valued at $277,000 after purchasing an additional 13 shares during the last quarter. Danske Bank A S boosted its holdings in Mettler-Toledo International by 16.0% during the third quarter. Danske Bank A S now owns 5,045 shares of the medical instruments supplier’s stock worth $7,623,000 after buying an additional 697 shares in the last quarter. Aberdeen Group plc grew its holdings in Mettler-Toledo International by 1,214.7% in the third quarter. Aberdeen Group plc now owns 245,978 shares of the medical instruments supplier’s stock valued at $371,660,000 after purchasing an additional 227,268 shares during the period. Allworth Financial LP grew its holdings in Mettler-Toledo International by 11.9% in the third quarter. Allworth Financial LP now owns 254 shares of the medical instruments supplier’s stock valued at $384,000 after purchasing an additional 27 shares during the period. Finally, Russell Investments Group Ltd. grew its holdings in Mettler-Toledo International by 6.9% in the third quarter. Russell Investments Group Ltd. now owns 130,556 shares of the medical instruments supplier’s stock valued at $197,385,000 after purchasing an additional 8,442 shares during the period. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes.

The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.